honokiol has been researched along with Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Kong, Q; Li, Z; Lv, L; Zhang, Y | 1 |
| Bauer, R; Bernaskova, M; Huefner, A; Kretschmer, N; Schuehly, W; Weis, R | 1 |
| Bai, P; Bian, Y; Cheng, Z; Liang, L; Wan, J; Wang, F; Wang, S; Xue, F | 1 |
| Arbiser, JL; Bonner, MY; Cebula-Obrzut, B; Majchrzak, A; Mędra, A; Robak, T; Smolewski, P; Witkowska, M | 1 |
| Wang, Y; Yang, Z; Zhao, X | 1 |
| Gong, YP; Guo, Y; Lin, J; Shan, QQ; Yang, X; Zhou, RQ | 1 |
| Wang, Y; Yang, Z; Zhao, X; Zhu, X | 1 |
7 other study(ies) available for honokiol and Leukemia
| Article | Year |
|---|---|
Honokiol Provides Cardioprotection from Myocardial Ischemia/Reperfusion Injury (MI/RI) by Inhibiting Mitochondrial Apoptosis via the PI3K/AKT Signaling Pathway.
Topics: Animals; Apoptosis; Biphenyl Compounds; Humans; Leukemia; Lignans; Lymphoma, B-Cell; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2022 |
Synthesis of tetrahydrohonokiol derivates and their evaluation for cytotoxic activity against CCRF-CEM leukemia, U251 glioblastoma and HCT-116 colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Glioblastoma; HCT116 Cells; Humans; Inhibitory Concentration 50; Leukemia; Lignans; Methylation; Microwaves | 2014 |
[Honokiol inhibits the invasion and angiogenesis of U937 leukemia cells].
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Lignans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Lignans; Lymphoma; Multiple Myeloma; Trityl Compounds | 2016 |
Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Biphenyl Compounds; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Drug Administration Schedule; Drug Synergism; Humans; Imatinib Mesylate; Leukemia; Lignans; Piperazines; Pyrimidines; Vacuoles | 2010 |
[Anti-tumor effect of tanshinone II A, tetrandrine, honokiol, curcumin, oridonin and paeonol on leukemia cell lines].
Topics: Abietanes; Acetophenones; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Curcumin; Diterpenes, Kaurane; Drugs, Chinese Herbal; HL-60 Cells; Humans; K562 Cells; Leukemia; Lignans; Plants, Medicinal | 2012 |
Honokiol induces caspase-independent paraptosis via reactive oxygen species production that is accompanied by apoptosis in leukemia cells.
Topics: Apoptosis; Biphenyl Compounds; Caspases; Cell Line, Tumor; Cell Membrane; Cytoplasm; Endoplasmic Reticulum; Humans; Leukemia; Lignans; Metabolic Networks and Pathways; Necrosis; Phosphatidylserines; Reactive Oxygen Species; Vacuoles | 2013 |